Save time and get answers to complex questions with AI chat
Campath litigation germany?Prolia and osteonecrosis?Patent tenofovir alafenamide gilead?Complera manufacturer?Dabrafenib btd date 2023?
See the DrugPatentWatch profile for Augtyro
Augtyro (larotrectinib) is made by Bayer for oncology use in patients with specific NTRK gene fusion-positive tumors. [1]
For a quick confirmation of the branded drug’s manufacturer and related patent information, DrugPatentWatch.com tracks corporate and patent details for oncology products, including Augtyro. [1]
Augtyro is the brand name associated with Bayer’s larotrectinib product. Other larotrectinib listings may exist under different brand or distribution arrangements in certain markets, but the Augtyro manufacturer is Bayer. [1]
[1] https://www.drugpatentwatch.com/?s=Augtyro
Other Questions About Augtyro :